These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases. Ardesjö B, Hansson CM, Bruder CE, Rorsman F, Betterle C, Dumanski JP, Kämpe O, Ekwall O. J Autoimmun; 2008 Jun; 30(4):273-82. PubMed ID: 18242955 [Abstract] [Full Text] [Related]
6. Surgical outcome in patients with primary sclerosing cholangitis undergoing ileal pouch-anal anastomosis: a case-control study. Gorgun E, Remzi FH, Manilich E, Preen M, Shen B, Fazio VW. Surgery; 2005 Oct; 138(4):631-7; discussion 637-9. PubMed ID: 16269291 [Abstract] [Full Text] [Related]
7. Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis. Karlsen TH, Hampe J, Wiencke K, Schrumpf E, Thorsby E, Lie BA, Broomé U, Schreiber S, Boberg KM. Am J Gastroenterol; 2007 Jan; 102(1):115-21. PubMed ID: 17100974 [Abstract] [Full Text] [Related]
8. Fatigue in patients with primary sclerosing cholangitis. Björnsson E, Simren M, Olsson R, Chapman RW. Scand J Gastroenterol; 2004 Oct; 39(10):961-8. PubMed ID: 15513335 [Abstract] [Full Text] [Related]
20. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH. Scand J Gastroenterol; 2009 Oct; 44(1):46-55. PubMed ID: 18609187 [Abstract] [Full Text] [Related] Page: [Next] [New Search]